Treatment of hypertension with an angiotensin II—receptor antagonist compared with an angiotensin-converting enzyme inhibitor: A review of clinical studies of telmisartan and enalapril-Reference-Cited by-同舟云学术

Treatment of hypertension with an angiotensin II—receptor antagonist compared with an angiotensin-converting enzyme inhibitor: A review of clinical studies of telmisartan and enalapril

Published:2002-10 Issue:10 Volume:24 Page:1484-1501
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Smith David H.G.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference86 articles.

1. Angiotensin II receptor antagonists;Ruddy,2000

2. Angiotensin II receptor blockade and end-organ protection: Pharmacological rationale and evidence;Unger;J Hypertens Suppl,1998

3. Novel mechanisms linking angiotensin II and early atherogenesis;Strawn;J Renin Angiotensin Aldosterone Syst,2000

4. Angiotensin receptor blocker selectivity at the AT1- and AT2-receptors: Conceptual and clinical effects;Unger;J Renin Angiotensin Aldosterone Syst,2000

5. Beyond blood pressure: New roles for angiotensin II;Lucius;Cell Mol Life Sci,1999

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of MT-1207: A Novel, Potent Multitarget Inhibitor as a Promising Clinical Candidate for the Treatment of Hypertension;Journal of Medicinal Chemistry;2024-07-05

2. A Validated RP-HPLC Method for Simultaneous Estimation of Benidipine and Telmisartan in Bulk and Tablet Dosage Form;Asian Journal of Pharmaceutical Analysis;2023-11-23

3. Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure;Canadian Journal of Cardiology;2020-05

4. Evolution of a New Class of Antihypertensive Drugs;Hypertension;2020-01

5. Telmisartan protects against high glucose/high lipid‐induced apoptosis and insulin secretion by reducing the oxidative and ER stress;Cell Biochemistry and Function;2019-03-25